CTK Balance Sheet Health
Financial Health criteria checks 5/6
CTK has a total shareholder equity of ₩157.8B and total debt of ₩10.3B, which brings its debt-to-equity ratio to 6.5%. Its total assets and total liabilities are ₩194.2B and ₩36.5B respectively. CTK's EBIT is ₩651.3M making its interest coverage ratio -0.4. It has cash and short-term investments of ₩50.4B.
Key information
6.5%
Debt to equity ratio
₩10.27b
Debt
| Interest coverage ratio | -0.4x |
| Cash | ₩50.41b |
| Equity | ₩157.76b |
| Total liabilities | ₩36.45b |
| Total assets | ₩194.21b |
Recent financial health updates
CTK (KOSDAQ:260930) Has A Rock Solid Balance Sheet
May 05
Is CTK Cosmetics (KOSDAQ:260930) A Risky Investment?
Apr 14Is CTK Cosmetics (KOSDAQ:260930) Using Debt Sensibly?
Dec 23Recent updates
Positive Sentiment Still Eludes CTK Co., Ltd (KOSDAQ:260930) Following 27% Share Price Slump
Jul 15CTK Co., Ltd's (KOSDAQ:260930) 31% Price Boost Is Out Of Tune With Revenues
May 12CTK (KOSDAQ:260930) Has A Rock Solid Balance Sheet
May 05Shareholders Will Be Pleased With The Quality of CTK's (KOSDAQ:260930) Earnings
Mar 31Is CTK Cosmetics (KOSDAQ:260930) A Risky Investment?
Apr 14CTK Cosmetics (KOSDAQ:260930) Shareholders Have Enjoyed A 88% Share Price Gain
Mar 16How Does CTK Cosmetics Co., Ltd (KOSDAQ:260930) Fare As A Dividend Stock?
Feb 17
What Type Of Shareholders Own The Most Number of CTK Cosmetics Co., Ltd (KOSDAQ:260930) Shares?
Jan 18Is CTK Cosmetics (KOSDAQ:260930) Using Debt Sensibly?
Dec 23Investors Who Bought CTK Cosmetics (KOSDAQ:260930) Shares A Year Ago Are Now Up 13%
Nov 25Financial Position Analysis
Short Term Liabilities: A260930's short term assets (₩82.8B) exceed its short term liabilities (₩34.0B).
Long Term Liabilities: A260930's short term assets (₩82.8B) exceed its long term liabilities (₩2.5B).
Debt to Equity History and Analysis
Debt Level: A260930 has more cash than its total debt.
Reducing Debt: A260930's debt to equity ratio has increased from 1% to 6.5% over the past 5 years.
Debt Coverage: A260930's debt is well covered by operating cash flow (51.2%).
Interest Coverage: A260930 earns more interest than it pays, so coverage of interest payments is not a concern.